Rab Prinjha

Direktor/Vorstandsmitglied bei Padlock Therapeutics, Inc.

Health Technology

Consumer Services

Aktive Positionen von Rab Prinjha

Unternehmen	Position	Beginn	Ende
Padlock Therapeutics, Inc. Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
GSK PLC	Corporate Officer/Principal	-	-

University College London

Doctorate Degree

International

Vereinigtes Königreich	3
Vereinigte Staaten	2

Operativ

Director/Board Member	1
Doctorate Degree	1
Corporate Officer/Principal	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
GSK PLC	Health Technology

Private Unternehmen	1
Padlock Therapeutics, Inc. Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.	Health Technology

Private Unternehmen

Health Technology